Tags

Type your tag names separated by a space and hit enter

Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep 2006; 55(RR-12):1-13MR

Abstract

In February 2006, a live, oral, human-bovine reassortant rotavirus vaccine (RotaTeq) was licensed for use among U.S. infants. The Advisory Committee on Immunization Practices recommends routine vaccination of U.S. infants with 3 doses of this rotavirus vaccine administered orally at ages 2, 4, and 6 months. The first dose should be administered between ages 6-12 weeks. Subsequent doses should be administered at 4-10 week intervals, and all 3 doses should be administered by age 32 weeks. Rotavirus vaccine can be co-administered with other childhood vaccines. Rotavirus vaccine is contraindicated for infants with a serious allergic reaction to any vaccine component or to a previous dose of vaccine.

Authors+Show Affiliations

Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Rd., NE. MS A-34, Atlanta, GA 30333, USA. uap2@cdc.govNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Practice Guideline

Language

eng

PubMed ID

16902398

Citation

Parashar, Umesh D., et al. "Prevention of Rotavirus Gastroenteritis Among Infants and Children. Recommendations of the Advisory Committee On Immunization Practices (ACIP)." MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports, vol. 55, no. RR-12, 2006, pp. 1-13.
Parashar UD, Alexander JP, Glass RI, et al. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-12):1-13.
Parashar, U. D., Alexander, J. P., & Glass, R. I. (2006). Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports, 55(RR-12), pp. 1-13.
Parashar UD, et al. Prevention of Rotavirus Gastroenteritis Among Infants and Children. Recommendations of the Advisory Committee On Immunization Practices (ACIP). MMWR Recomm Rep. 2006 Aug 11;55(RR-12):1-13. PubMed PMID: 16902398.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). AU - Parashar,Umesh D, AU - Alexander,James P, AU - Glass,Roger I, AU - ,, PY - 2006/8/12/pubmed PY - 2006/8/15/medline PY - 2006/8/12/entrez SP - 1 EP - 13 JF - MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports JO - MMWR Recomm Rep VL - 55 IS - RR-12 N2 - In February 2006, a live, oral, human-bovine reassortant rotavirus vaccine (RotaTeq) was licensed for use among U.S. infants. The Advisory Committee on Immunization Practices recommends routine vaccination of U.S. infants with 3 doses of this rotavirus vaccine administered orally at ages 2, 4, and 6 months. The first dose should be administered between ages 6-12 weeks. Subsequent doses should be administered at 4-10 week intervals, and all 3 doses should be administered by age 32 weeks. Rotavirus vaccine can be co-administered with other childhood vaccines. Rotavirus vaccine is contraindicated for infants with a serious allergic reaction to any vaccine component or to a previous dose of vaccine. SN - 1545-8601 UR - https://www.unboundmedicine.com/medline/citation/16902398/Prevention_of_rotavirus_gastroenteritis_among_infants_and_children__Recommendations_of_the_Advisory_Committee_on_Immunization_Practices__ACIP__ L2 - https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5512a1.htm DB - PRIME DP - Unbound Medicine ER -